# Immunomodulatory Profile of Dexmedetomidine Sedation in Patients Recovering After ARDS Covid-19

> **NCT04413864** · NA · UNKNOWN · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 50 (estimated)

## Conditions studied

- SARS-CoV 2

## Interventions

- **OTHER:** Inflammatory cytokines and chemokines profiles of patients with dexmedetomidine administration

## Key facts

- **NCT ID:** NCT04413864
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-04-24
- **Primary completion:** 2022-10-24
- **Final completion:** 2022-10-24
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2021-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04413864

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04413864, "Immunomodulatory Profile of Dexmedetomidine Sedation in Patients Recovering After ARDS Covid-19". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT04413864. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*